What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Surgery
The scientist’s investigation covers issues in Immunology, Dementia, Multicenter AIDS Cohort Study, Acquired immunodeficiency syndrome and Cohort study.
His Immunology research integrates issues from Total body irradiation, Cyclophosphamide, Methylprednisolone and Hematopoietic stem cell transplantation.
His studies deal with areas such as Beta-2 microglobulin, Central nervous system disease, Branched DNA assay, Pediatrics and Cohort as well as Dementia.
His work deals with themes such as Gastroenterology and Internal medicine, Asymptomatic, which intersect with Multicenter AIDS Cohort Study.
The Internal medicine study combines topics in areas such as Physical therapy, Surgery and Depression.
His Cohort study research includes elements of Psychiatry, Incidence and Neuropsychology.
His most cited work include:
- Mitochondrial Myopathy Caused by Long-Term Zidovudine Therapy (719 citations)
- Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection (642 citations)
- Dementia in AIDS patients: Incidence and risk factors (602 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Immunology, Multiple sclerosis, Pathology and Acquired immunodeficiency syndrome.
His study in Internal medicine is interdisciplinary in nature, drawing from both Placebo, Surgery and Oncology.
His Immunology research is multidisciplinary, incorporating perspectives in Gastroenterology and Hematopoietic stem cell transplantation.
His Hematopoietic stem cell transplantation research focuses on subjects like Total body irradiation, which are linked to Transplantation and Immunosuppression.
The various areas that Bruce Cohen examines in his Multiple sclerosis study include Physical therapy, Clinical trial, Disease and Neurology.
The concepts of his Dementia study are interwoven with issues in Epidemiology and Cohort.
He most often published in these fields:
- Internal medicine (32.68%)
- Immunology (33.33%)
- Multiple sclerosis (22.88%)
What were the highlights of his more recent work (between 2009-2021)?
- Multiple sclerosis (22.88%)
- Internal medicine (32.68%)
- Physical therapy (15.03%)
In recent papers he was focusing on the following fields of study:
Bruce Cohen focuses on Multiple sclerosis, Internal medicine, Physical therapy, Immunology and Placebo.
His Multiple sclerosis research is multidisciplinary, relying on both Radiology, Clinical trial and Disease.
The Clinical trial study which covers Magnetic resonance imaging that intersects with Pathology and Putamen.
His research in the fields of Cohort and Randomized controlled trial overlaps with other disciplines such as In patient.
Bruce Cohen combines subjects such as Neurocognitive, Hematopoietic stem cell transplantation, Transplantation and Autoimmune disease with his study of Immunology.
Bruce Cohen has included themes like Gastroenterology and Tolerability, Adverse effect in his Placebo study.
Between 2009 and 2021, his most popular works were:
- Subcortical brain atrophy persists even in HAART-regulated HIV disease (123 citations)
- Phase 2 trial of ibudilast in progressive multiple sclerosis (107 citations)
- A randomized trial of stress management for the prevention of new brain lesions in MS (85 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Surgery
His primary areas of investigation include Internal medicine, Multiple sclerosis, Magnetic resonance imaging, Atrophy and Clinical trial.
His Internal medicine research is multidisciplinary, incorporating elements of Immunology, Placebo and Physical therapy.
Bruce Cohen has researched Immunology in several fields, including Post hoc and Oncology.
Bruce Cohen studied Physical therapy and Odds ratio that intersect with Cohort study.
Bruce Cohen interconnects Caudate nucleus, Neuropsychology and Pathology in the investigation of issues within Magnetic resonance imaging.
His Clinical trial research integrates issues from Electrocardiography and Quality of life.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
